Helix 12 directed steroidal pharmaceutical products

Details for Australian Patent Application No. 2005203922 (hide)

Owner Endorecherche, Inc.

Inventors Frechette, Yvon; Singh, Shankar; Gauthier, Sylvain; Labrie, Fernand; Chenard, Sylvain; Breton, Rock

Agent Griffith Hack

Pub. Number AU-A-2005203922

PCT Pub. Number WO2005/066194

Priority 60/535,121 07.01.04 US

Filing date 6 January 2005

Wipo publication date 21 July 2005

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 35/00 (2006.01) Antineoplastic agents

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066194 Priority application(s): WO2005/066194

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005203924-Polypropylene modification for improved adhesion of polypropylenebased multilayer packaging film structure to vacuum deposited aluminum

2005203920-Cathepsin cysteine protease inhibitors